Carolyn Little, | |
9346 Oak Ave, Waconia, MN 55387-9422 | |
(952) 223-2506 | |
Not Available |
Full Name | Carolyn Little |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 9346 Oak Ave, Waconia, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184485567 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Carolyn Little, 9346 Oak Ave, Waconia, MN 55387-9422 Ph: (952) 223-2506 | Carolyn Little, 9346 Oak Ave, Waconia, MN 55387-9422 Ph: (952) 223-2506 |
News Archive
IntelGenx Corp. (TSX VENTURE:IGX)(OTCBB:IGXT) ("IntelGenx") previously announced that the New Drug Application (NDA) filing for the antidepressant CPI-300, which it developed with Cary Pharmaceuticals ("Cary Pharma") had been accepted by the U.S. Food and Drug Administration (FDA) for standard review. CPI-300 is a novel, high strength of Bupropion HCl, the active ingredient in Wellbutrin XL®.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will present new results from its clinical studies with blinatumomab at the 51st annual meeting of the American Society of Hematology from December 5-8, 2009 in New Orleans, Louisiana.
Even though a majority of U.S. oncologists report satisfaction with their careers, many say they have experienced at least one symptom of burnout, a Mayo Clinic-led study has found. The study was released during the American Society of Clinical Oncology's annual meeting in Chicago.
Optimer Pharmaceuticals, Inc. has announced that the United States Patent and Trademark Office issued a production patent (U.S. Patent No. 7,507,564) covering steps used in the manufacture of fidaxomicin, which is currently in its second Phase 3 clinical trial for the treatment of Clostridium difficile infection, or CDI.
› Verified 8 days ago
Nora Carlson, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Kirstin Amber Peters, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Andrea Elizabeth Guimont, MS, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Jami Eilers, MA, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Madelin Roberts, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Cerena Ice, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Christina Dalki, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 |